Demeter F, Bihari G, Vadicsku D, Sinkovits G, Kajdacsi E, Horvath L
Int J Mol Sci. 2024; 25(18).
PMID: 39337495
PMC: 11432022.
DOI: 10.3390/ijms251810007.
van Olden M, de Jong-Hesse Y, Vollebregt T, de Groot S, Luelmo S, Marinkovic M
Case Rep Ophthalmol. 2024; 15(1):184-188.
PMID: 38456120
PMC: 10919912.
DOI: 10.1159/000536572.
Oskam J, Danesh-Meyer H
Graefes Arch Clin Exp Ophthalmol. 2024; 262(7):2269-2281.
PMID: 38345654
PMC: 11222285.
DOI: 10.1007/s00417-023-06350-4.
Ghimire A, Brassington R, Solez K, Bello A
BMJ Case Rep. 2024; 17(1).
PMID: 38182165
PMC: 10773325.
DOI: 10.1136/bcr-2023-255841.
Lin J, Chen W, Zhong S, Qian K, Chen H, Lin L
Front Pharmacol. 2024; 14:1255785.
PMID: 38169843
PMC: 10758437.
DOI: 10.3389/fphar.2023.1255785.
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.
Sakellakis M, Spathas N, Tsaousis K, Nikitiadis E, Linardou H, Diakonis V
Cureus. 2022; 14(7):e27266.
PMID: 36039252
PMC: 9403378.
DOI: 10.7759/cureus.27266.
Ocular Toxicity of Targeted Anticancer Agents.
Fortes B, Tailor P, Dalvin L
Drugs. 2021; 81(7):771-823.
PMID: 33788182
DOI: 10.1007/s40265-021-01507-z.
An Interesting Case: Sunitinib-Induced Microangiopathic Hemolytic Anemia and Nephrotic Syndrome.
Haksoyler V, Paydas S
Turk J Haematol. 2020; 38(2):163-165.
PMID: 33121226
PMC: 8171212.
DOI: 10.4274/tjh.galenos.2020.2020.0532.
Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report.
Patwari A, Bhatlapenumarthi V, Pascual S
Case Rep Oncol. 2020; 13(2):1013-1019.
PMID: 32999665
PMC: 7506375.
DOI: 10.1159/000509640.
An Update in Drug-Induced Thrombotic Microangiopathy.
Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, Gavriilaki E
Front Med (Lausanne). 2020; 7:212.
PMID: 32528969
PMC: 7256484.
DOI: 10.3389/fmed.2020.00212.
Posterior Reversible Encephalopathy Syndrome: Pattern on F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Correlated with Magnetic Resonance Imaging in Pediatric Hypertensive Encephalopathy.
Arora S, Passah A, Nalli H, Goyal H, Tripathi M, Shamim S
Indian J Nucl Med. 2020; 35(1):72-73.
PMID: 31949377
PMC: 6958944.
DOI: 10.4103/ijnm.IJNM_149_19.
Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
Liu Y, Zhou L, Chen Y, Liao B, Ye D, Wang K
BMC Urol. 2019; 19(1):49.
PMID: 31174518
PMC: 6555944.
DOI: 10.1186/s12894-019-0481-5.
Unusual Pattern of Whitening of Eyebrows Following Sunitinib Therapy: A Case Report with Brief Review of Literature.
Agrawal C, Talwar V, Babu V, Jain P, Goyal P
Int J Trichology. 2017; 9(4):190-192.
PMID: 29118527
PMC: 5655631.
DOI: 10.4103/ijt.ijt_20_17.
Neuro-ophthalmic side effects of molecularly targeted cancer drugs.
Bhatti M, Salama A
Eye (Lond). 2017; 32(2):287-301.
PMID: 29052609
PMC: 5811730.
DOI: 10.1038/eye.2017.222.
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors.
Negrier S, Perol D, Bahleda R, Hollebecque A, Chatelut E, Boyle H
BMC Cancer. 2017; 17(1):547.
PMID: 28810837
PMC: 5558713.
DOI: 10.1186/s12885-017-3527-7.
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?.
Shah R
Drug Saf. 2017; 40(5):373-386.
PMID: 28181126
DOI: 10.1007/s40264-017-0508-3.
Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Agents: A Case Report.
Dos Reis Simoes da Silva F, Burgos Pego P, Henriques Vendrell M, de Azevedo Batalha Ferreira Dos Santos Farias M, Ribeiro Timoteo A, Martins da Costa M
Neuroophthalmology. 2016; 35(1):32-37.
PMID: 27956931
PMC: 5145282.
DOI: 10.3109/01658107.2010.539763.
Sunitinib-induced sudden hearing loss.
Dekeister K, Graillot E, Durbec M, Scoazec J, Walter T
Invest New Drugs. 2016; 34(6):792-793.
PMID: 27474033
DOI: 10.1007/s10637-016-0378-z.
Cancer-associated thrombotic microangiopathy.
Govind Babu K, Bhat G
Ecancermedicalscience. 2016; 10:649.
PMID: 27433282
PMC: 4929977.
DOI: 10.3332/ecancer.2016.649.
Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.
Kamiya-Matsuoka C, Paker A, Chi L, Youssef A, Tummala S, Loghin M
J Neurooncol. 2016; 128(1):75-84.
PMID: 26900076
DOI: 10.1007/s11060-016-2078-0.
